According to Regulus Therapeutics's latest financial reports the company's current earnings (TTM) are -S$45.59 M. In 2023 the company made an earning of -S$38.34 M a decrease over its 2022 earnings that were of -S$36 M.The earnings displayed on this page is the company's Pretax Income.